| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2134* | 2021 |
| RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19 P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, ... N Engl J Med 384 (8), 693-704, 2021 | 636* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 490* | 2022 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 220 | 2021 |
| Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus H Iqbal, S Straw, TP Craven, K Stirling, SB Wheatcroft, KK Witte ESC Heart Failure 7 (5), 2032-2041, 2020 | 94 | 2020 |
| Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery S Straw, MW Baig, R Gillott, J Wu, KK Witte, DJ O’regan, JAT Sandoe Clinical Infectious Diseases 71 (3), 564-571, 2020 | 94 | 2020 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 91 | 2022 |
| Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study M Drozd, M Pujades-Rodriguez, PJ Lillie, S Straw, AW Morgan, ... The Lancet Infectious Diseases 21 (8), 1184-1191, 2021 | 74 | 2021 |
| Predicting one‐year mortality in heart failure using the ‘Surprise Question’: A prospective pilot study S Straw, R Byrom, J Gierula, MF Paton, A Koshy, R Cubbon, M Drozd, ... European Journal of Heart Failure 21 (2), 227-234, 2019 | 62 | 2019 |
| Infection-related hospitalization in heart failure with reduced ejection fraction: a prospective observational cohort study M Drozd, E Garland, AMN Walker, TA Slater, A Koshy, S Straw, J Gierula, ... Circulation: Heart Failure 13 (5), e006746, 2020 | 60 | 2020 |
| Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction S Straw, M McGinlay, KK Witte Open Heart 8 (1), e001585, 2021 | 59 | 2021 |
| Prioritizing symptom management in the treatment of chronic heart failure AO Koshy, ER Gallivan, M McGinlay, S Straw, M Drozd, AG Toms, ... ESC heart failure 7 (5), 2193-2207, 2020 | 54 | 2020 |
| Empagliflozin treatment is associated with improvements in cardiac energetics and function and reductions in myocardial cellular volume in patients with type 2 diabetes S Thirunavukarasu, N Jex, A Chowdhary, IU Hassan, S Straw, TP Craven, ... Diabetes 70 (12), 2810-2822, 2021 | 52 | 2021 |
| Association of heart failure and its comorbidities with loss of life expectancy M Drozd, SD Relton, AMN Walker, TA Slater, J Gierula, MF Paton, J Lowry, ... Heart 107 (17), 1417-1421, 2021 | 50 | 2021 |
| Dying ‘due to’or ‘with’COVID-19: a cause of death analysis in hospitalised patients TA Slater, S Straw, M Drozd, S Kamalathasan, A Cowley, KK Witte Clinical medicine 20 (5), e189-e190, 2020 | 47 | 2020 |
| Relationship among diabetes, obesity, and cardiovascular disease phenotypes: a UK biobank cohort study OI Brown, M Drozd, H McGowan, M Giannoudi, M Conning-Rowland, ... Diabetes Care 46 (8), 1531-1540, 2023 | 38 | 2023 |
| Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data S Straw, M McGinlay, M Drozd, TA Slater, A Cowley, S Kamalathasan, ... BMC Palliative Care 20, 1-11, 2021 | 27 | 2021 |
| Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence N Wood, S Straw, M Scalabrin, LD Roberts, KK Witte, TS Bowen ESC heart failure 8 (1), 3-15, 2021 | 27 | 2021 |
| To the editor—New phones, old problem? Interference with cardiovascular implantable electronic devices by phones containing magnets Z Patterson, S Straw, M Drozd, MF Paton, C Cole, KK Witte, J Gierula Heart Rhythm 18 (6), 1041, 2021 | 15 | 2021 |
| Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes V Palin, M Drozd, E Garland, A Malik, S Straw, M McGinlay, A Simms, ... ESC Heart Failure 9 (5), 3298-3307, 2022 | 13 | 2022 |
